# Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

> **NCT00524589** · PHASE2 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 18 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** calcitriol
- **DRUG:** dexamethasone
- **GENETIC:** protein expression analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00524589
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-09
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** closed due to futility
- **Last updated:** 2017-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00524589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00524589, "Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00524589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*